SEC Form 4 · accession 0001209191-15-032530
Receptos, Inc. · RCPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Peach
Officer — Chief Scientific Officer
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001463729
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2015 | A | 7,000 | $0.00 | A | 138,297 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents time-based restricted stock units which vest in four equal annual installments on the anniversary of the date of grant. An additional 7,000 performance-based restricted stock units will vest, if at all, upon the first filing of a New Drug Application (or foreign equivalent) by Receptos, Inc. (the "Company") for any of the Company's product candidates in any geography within 10 years of the date of grant.
Remarks
Exhibit Index: Exhibit 24 - Power of Attorney